XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Mar. 30, 2024
Apr. 01, 2023
OPERATING ACTIVITIES:    
Net (loss) income $ (4.1) $ 25.6
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation expense 29.1 26.4
Amortization of acquired technologies and other intangibles 15.4 25.2
Stock-based compensation 36.6 38.8
Loss on convertible note modification 0.0 2.2
Amortization of debt issuance costs 5.6 2.3
Net change in fair value of contingent liabilities (7.8) (0.2)
Deferred taxes, net (2.3) 4.1
Restructuring (0.8) 10.2
Gain on legal settlement 0.0 (6.7)
Other 1.7 4.3
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 17.4 47.6
Inventories 6.7 (20.0)
Other current and non-currents assets 3.7 19.0
Accounts payable (4.1) (13.3)
Income taxes payable 2.3 (6.2)
Deferred revenue, current and non-current (15.7) (6.3)
Accrued payroll and related expenses (8.1) (35.1)
Accrued expenses and other current and non-current liabilities 14.6 (27.3)
Net cash provided by operating activities 90.2 90.6
INVESTING ACTIVITIES:    
Purchases of short-term investments (188.3) 0.0
Maturities of short-term investments 174.2 0.0
Capital expenditures (15.7) (43.7)
Proceeds from the sale of assets 2.6 3.5
Acquisitions, net of cash hold back 0.0 (64.4)
Purchase price adjustment related to business acquisition 0.0 (0.7)
Net cash used in investing activities (27.2) (105.3)
FINANCING ACTIVITIES:    
Proceeds from issuance of debt 0.0 118.0
Payment of debt issuance costs 0.0 (3.9)
Retirement of convertible notes upon maturity (96.4) 0.0
Repurchase and retirement of common stock (10.0) (73.9)
Withholding tax payment on vesting of restricted stock and performance- based awards (11.0) (11.4)
Payment of financing obligations (0.2) (0.1)
Proceeds from employee stock purchase plan 6.3 7.9
Payment of acquisition related contingent considerations and obligations (4.0) (7.3)
Net cash (used in) provided by financing activities (115.3) 29.3
Effect of exchange rates on cash, cash equivalents and restricted cash (0.2) 5.8
Net (decrease) increase in cash, cash equivalents and restricted cash (52.5) 20.4
Cash, cash equivalents and restricted cash at the beginning of the period [1] 515.6 572.8
Cash, cash equivalents and restricted cash at the end of the period [2] $ 463.1 $ 593.2
[1] These amounts include both current and non-current balances of restricted cash totaling $9.1 million and $12.9 million as of July 1, 2023 and July 2, 2022, respectively.
[2] These amounts include both current and non-current balances of restricted cash totaling $8.9 million and $12.6 million as of March 30, 2024 and April 1, 2023, respectively.